STOCK TITAN
  1. Home
  2. TDACU

Translational Dev Acquisition Stock Price, News & Analysis

TDACU NASDAQ

Company Description

Welcome to the overview page for Translational Dev Acquisition (TDACU), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+4.3%
Performance 1 year
$0.0
Market Cap
20.1M
Shares outstanding

Latest News

View All
February 14, 2025
+0.05%

Translational Development Acquisition Corp. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced

acquisition
December 24, 2024
0.00%

Translational Development Acquisition Corp. Announces Closing of $172.5 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option

IPO offering acquisition
December 23, 2024
-45.72%

Translational Development Acquisition Corp. Announces the Pricing of $150,000,000 Initial Public Offering

IPO offering acquisition
June 30, 2021
+2.42%

Trident Acquisitions Corp. Files 10-Q and is in Compliance with Nasdaq Reporting Rules

acquisition
June 25, 2021
+2.42%

Trident Acquisitions Corp. Files 10K/A

acquisition
June 2, 2021
+0.48%

Trident Acquisitions Corp. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

acquisition

SEC Filings

View All

No SEC filings available for Translational Dev Acquisition.

Financial Highlights

View Full Financials
-$71K
Net Income (TTM)
-$851K
Operating Cash Flow
3.09
Current Ratio
-$196K
Operating Income
—
Revenue (TTM)
—
Diluted EPS (TTM)

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Translational Dev Acquisition (TDACU) currently stands at 1 shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 100%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Translational Dev Acquisition (TDACU) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.1 days.

Related Stocks

BEAGU Bold Eagle Acquisition Corp
HONDW HCM II Acquisition Corp
ALDFU Aldel Financial II
CAPNU Cayson Acquisition Corp
CHARU Charlton Aria Acquisition Corp
FVNNU Future Vision II Acquisition Corp
ISRLU Israel Acquisitions Corp
RDACU Rising Dragon Acquisition Corp.

Frequently Asked Questions

What is the current stock price of Translational Dev Acquisition (TDACU)?

The current stock price of Translational Dev Acquisition (TDACU) is $10.44 as of October 6, 2025.

What is the net income of Translational Dev Acquisition (TDACU)?

The trailing twelve months (TTM) net income of Translational Dev Acquisition (TDACU) is -$71K.

What is the operating cash flow of Translational Dev Acquisition (TDACU)?

The operating cash flow of Translational Dev Acquisition (TDACU) is -$851K. Learn about cash flow.

What is the current ratio of Translational Dev Acquisition (TDACU)?

The current ratio of Translational Dev Acquisition (TDACU) is 3.09, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Translational Dev Acquisition (TDACU)?

The operating income of Translational Dev Acquisition (TDACU) is -$196K. Learn about operating income.